Intensity Therapeutics Inc.
INTS | NASDAQ
$4.02
-$0.09 (-2.19%)
At close: Sep 21, 2026, 4:00 PM ET
$4.01
-$0.01 (-0.25%)
Pre-market:
Sep 22, 2026, 7:10 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 26K | n/a | 147K | n/a | n/a | n/a |
Gross Profit | -26K | n/a | -147K | n/a | n/a | n/a |
Operating Income | -11.97M | -16.59M | -8.32M | -7.55M | -8.01M | -6.22M |
Interest Income | 180K | 314K | 324K | 2.48K | 2.61K | 74.01K |
Pretax Income | -11.61M | -16.27M | -10.54M | -7.58M | -7.9M | -6.03M |
Net Income | -11.61M | -16.27M | -10.54M | -7.58M | -7.9M | -5.96M |
Selling & General & Admin | 5.19M | 6.09M | 3.39M | 2.42M | 2.14M | 1.17M |
Research & Development | 6.79M | 10.5M | 4.79M | 5.13M | 5.86M | 5.05M |
Other Expenses | n/a | n/a | n/a | n/a | 17.22K | n/a |
Operating Expenses | 11.97M | 16.59M | 8.17M | 7.55M | 8.01M | 6.22M |
Interest Expense | n/a | n/a | 305K | 81.78K | 16.77K | n/a |
Selling & Marketing Expenses | n/a | n/a | -147K | n/a | n/a | n/a |
Cost & Expenses | 11.97M | 16.59M | 8.32M | 7.55M | 8.01M | 6.22M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 13.56M | 556.24K | 306.16K | 136.4K | 136.4K | 136.36K |
Shares Outstanding (Diluted) | 13.56M | 556.28K | 344.65K | 136.4K | 136.4K | 136.38K |
EPS (Basic) | -8.56 | -29.25 | -34.50 | -55.50 | -58 | -44.25 |
EPS (Diluted) | -8.56 | -29.25 | -34.50 | -55.50 | -58 | -44.25 |
EBITDA | -11.61M | -16.27M | -10.09M | -7.32M | -7.88M | -6.03M |
EBIT | -11.61M | -16.27M | -10.23M | -7.5M | -7.88M | -6.03M |
Depreciation & Amortization | n/a | n/a | 147K | 179.04K | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove INTS